Equities

Pasithea Therapeutics Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
KTTA:NAQ

Pasithea Therapeutics Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.814
  • Today's Change-0.068 / -7.67%
  • Shares traded79.52k
  • 1 Year change-29.83%
  • Beta0.1989
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Monday, Pasithea Therapeutics Corp (KTTA:NAQ) closed at 0.814, 189.68% above the 52 week low of 0.281 set on Nov 21, 2025.
52-week range
Today
0.281Nov 21 20253.79May 06 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.88
High0.88
Low0.814
Bid0.77
Offer0.899
Previous close0.8816
Average volume176.60k
Shares outstanding23.09m
Free float22.72m
P/E (TTM)--
Market cap20.36m USD
EPS (TTM)-5.21
USD
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼

Events & Activity

  • KTTA:NAQ price falls below 200-day moving average to 0.8224 at 18:47 GMT
  • KTTA:NAQ price falls below 200-day moving average to 0.8151 at 14:47 GMT
  • KTTA:NAQ price moved over -5.57% to 0.8042
  • KTTA:NAQ price falls below 200-day moving average to 0.8042 at 14:43 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.